Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 6.32
RVP's Cash to Debt is ranked higher than
65% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. RVP: 6.32 )
Ranked among companies with meaningful Cash to Debt only.
RVP' s 10-Year Cash to Debt Range
Min: 0.06   Max: 24.08
Current: 6.32

0.06
24.08
Equity to Asset 0.58
RVP's Equity to Asset is ranked lower than
51% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. RVP: 0.58 )
Ranked among companies with meaningful Equity to Asset only.
RVP' s 10-Year Equity to Asset Range
Min: 0.01   Max: 0.86
Current: 0.58

0.01
0.86
F-Score: 5
Z-Score: 3.78
M-Score: -2.49
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -3.06
RVP's Operating margin (%) is ranked lower than
66% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.85 vs. RVP: -3.06 )
Ranked among companies with meaningful Operating margin (%) only.
RVP' s 10-Year Operating margin (%) Range
Min: -108.34   Max: -6.25
Current: -3.06

-108.34
-6.25
Net-margin (%) -3.64
RVP's Net-margin (%) is ranked lower than
67% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. RVP: -3.64 )
Ranked among companies with meaningful Net-margin (%) only.
RVP' s 10-Year Net-margin (%) Range
Min: -108.34   Max: 254.12
Current: -3.64

-108.34
254.12
ROE (%) -4.81
RVP's ROE (%) is ranked lower than
68% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.27 vs. RVP: -4.81 )
Ranked among companies with meaningful ROE (%) only.
RVP' s 10-Year ROE (%) Range
Min: -191.58   Max: 138.81
Current: -4.81

-191.58
138.81
ROA (%) -2.81
RVP's ROA (%) is ranked lower than
67% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.87 vs. RVP: -2.81 )
Ranked among companies with meaningful ROA (%) only.
RVP' s 10-Year ROA (%) Range
Min: -37.3   Max: 109.24
Current: -2.81

-37.3
109.24
ROC (Joel Greenblatt) (%) -9.57
RVP's ROC (Joel Greenblatt) (%) is ranked lower than
66% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.83 vs. RVP: -9.57 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
RVP' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -114.38   Max: -19.83
Current: -9.57

-114.38
-19.83
Revenue Growth (3Y)(%) 1.10
RVP's Revenue Growth (3Y)(%) is ranked lower than
63% of the 144 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. RVP: 1.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
RVP' s 10-Year Revenue Growth (3Y)(%) Range
Min: -7.9   Max: 15.3
Current: 1.1

-7.9
15.3
» RVP's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

RVP Guru Trades in Q2 2014

Jim Simons 19,300 sh (+78.70%)
» More
Q3 2014

RVP Guru Trades in Q3 2014

Jim Simons Sold Out
» More
Q4 2014

RVP Guru Trades in Q4 2014

Jim Simons 40,400 sh (New)
» More
Q1 2015

RVP Guru Trades in Q1 2015

Jim Simons 50,100 sh (+24.01%)
» More
» Details

Insider Trades

Latest Guru Trades with RVP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 4.40
RVP's P/B is ranked lower than
65% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.26 vs. RVP: 4.40 )
Ranked among companies with meaningful P/B only.
RVP' s 10-Year P/B Range
Min: 0.27   Max: 10.68
Current: 4.4

0.27
10.68
P/S 3.10
RVP's P/S is ranked lower than
74% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.22 vs. RVP: 3.10 )
Ranked among companies with meaningful P/S only.
RVP' s 10-Year P/S Range
Min: 0.39   Max: 9.19
Current: 3.1

0.39
9.19
Current Ratio 2.19
RVP's Current Ratio is ranked lower than
57% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. RVP: 2.19 )
Ranked among companies with meaningful Current Ratio only.
RVP' s 10-Year Current Ratio Range
Min: 0.55   Max: 11.46
Current: 2.19

0.55
11.46
Quick Ratio 1.82
RVP's Quick Ratio is ranked higher than
55% of the 177 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. RVP: 1.82 )
Ranked among companies with meaningful Quick Ratio only.
RVP' s 10-Year Quick Ratio Range
Min: 0.22   Max: 10.86
Current: 1.82

0.22
10.86
Days Inventory 86.18
RVP's Days Inventory is ranked higher than
74% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.06 vs. RVP: 86.18 )
Ranked among companies with meaningful Days Inventory only.
RVP' s 10-Year Days Inventory Range
Min: 65.68   Max: 133.86
Current: 86.18

65.68
133.86
Days Sales Outstanding 36.04
RVP's Days Sales Outstanding is ranked higher than
86% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.58 vs. RVP: 36.04 )
Ranked among companies with meaningful Days Sales Outstanding only.
RVP' s 10-Year Days Sales Outstanding Range
Min: 22.38   Max: 93.15
Current: 36.04

22.38
93.15

Valuation & Return

vs
industry
vs
history
Price/Net Cash 27.90
RVP's Price/Net Cash is ranked lower than
67% of the 72 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.30 vs. RVP: 27.90 )
Ranked among companies with meaningful Price/Net Cash only.
RVP' s 10-Year Price/Net Cash Range
Min: 1.2   Max: 424.5
Current: 27.9

1.2
424.5
Price/Net Current Asset Value 13.00
RVP's Price/Net Current Asset Value is ranked lower than
53% of the 105 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.20 vs. RVP: 13.00 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
RVP' s 10-Year Price/Net Current Asset Value Range
Min: 0.81   Max: 86
Current: 13

0.81
86
Price/Tangible Book 4.40
RVP's Price/Tangible Book is ranked higher than
57% of the 219 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. RVP: 4.40 )
Ranked among companies with meaningful Price/Tangible Book only.
RVP' s 10-Year Price/Tangible Book Range
Min: 0.46   Max: 785
Current: 4.4

0.46
785
Price/DCF (Projected) 5.00
RVP's Price/DCF (Projected) is ranked lower than
82% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.10 vs. RVP: 5.00 )
Ranked among companies with meaningful Price/DCF (Projected) only.
RVP' s 10-Year Price/DCF (Projected) Range
Min: 0.19   Max: 45
Current: 5

0.19
45
Price/Median PS Value 2.20
RVP's Price/Median PS Value is ranked lower than
93% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. RVP: 2.20 )
Ranked among companies with meaningful Price/Median PS Value only.
RVP' s 10-Year Price/Median PS Value Range
Min: 0.41   Max: 12.66
Current: 2.2

0.41
12.66
Earnings Yield (Greenblatt) -1.10
RVP's Earnings Yield (Greenblatt) is ranked lower than
64% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. RVP: -1.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
RVP' s 10-Year Earnings Yield (Greenblatt) Range
Min: -1.1   Max: 18028.8
Current: -1.1

-1.1
18028.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Retractable Technologies Inc was incorporated in Texas on May 9, 1994. The Company designs, develops, manufactures, and markets patented safety medical products for the healthcare industry. The Companys products with Notice of Substantial Equivalence to the U.S. Food and Drug Administration (FDA) and which are currently sold include the 1mL tuberculin; insulin; allergy antigen VanishPoint syringes; 3mL, 5mL, and 10mL VanishPoint syringes; the VanishPoint blood collection tube holder; the VanishPoint IV safety catheter; small diameter tube adapter; the Patient Safe syringe; the Patient Safe Luer Cap; and the VanishPoint Blood Collection Set. It is also selling autodisable syringes in the international market. The Companys VanishPoint safety products (consisting of 1mL tuberculin, insulin, and allergy antigen VanishPoint syringes; 0.5mL, 2ml, 3mL, 5mL, and 10mL VanishPoint syringes; VanishPoint autodisable syringe; the VanishPoint IV catheter; the VanishPoint blood collection tube holder; and the VanishPoint blood collection set. PatientSafe syringe products currently consist of 3mL, 5mL, 10mL, 20mL, 30mL, 60mL PatientSafe syringes and the PatientSafe luer cap. The PatientSafe syringe offers a patented design designed to protect patients by reducing the risk of bloodstream infections resulting from catheter hub contamination. The Company distributes its products throughout the U.S. and its territories through general line and specialty distributors. It also has trademark protection for the phrase The New Standard for Safety'. Its domestic competitors include BD and Covidien Ltd. (Covidien). Terumo Medical Corp. (Terumo), Smiths Medical, and B Braun are additional competitors with smaller market shares.
» More Articles for RVP

Headlines

Articles On GuruFocus.com
Retractable Technologies Inc (RVP) CEO Thomas J Shaw buys 200,000 Shares Mar 16 2009 

More From Other Websites
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers May 29 2015
RETRACTABLE TECHNOLOGIES INC Financials May 27 2015
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events May 22 2015
Retractable Technologies, Inc. Reports Recognition of Payment May 21 2015
Retractable Technologies, Inc. Reports Recognition of Payment May 21 2015
10-Q for Retractable Technologies, Inc. May 18 2015
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events May 18 2015
Retractable Technologies, Inc. Reports Improved Results for the First Quarter 2015 May 15 2015
Retractable Technologies posts 1Q loss May 15 2015
Retractable Technologies posts 1Q loss May 15 2015
Retractable Technologies, Inc. Reports Improved Results for the First Quarter 2015 May 15 2015
RETRACTABLE TECHNOLOGIES INC Files SEC form 10-Q, Quarterly Report May 15 2015
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events Apr 28 2015
Retractable Technologies, Inc. Announces Amended Final Judgment and Notice of Appeal Apr 27 2015
10-K for Retractable Technologies, Inc. Apr 25 2015
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 22 2015
Retractable Technologies, Inc. Announces U.S. Supreme Court Decision ? Denial of Writ of Certiorari Apr 21 2015
Retractable Technologies, Inc. Announces U.S. Supreme Court Decision – Denial of Writ of... Apr 21 2015
RETRACTABLE TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 09 2015
Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Preferred Stock... Apr 09 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK